Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.

metastasis urokinase urokinase inhibitors urokinase receptor urokinase receptor inhibitors

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
19 Jan 2022
Historique:
received: 18 11 2021
revised: 11 01 2022
accepted: 15 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 16 2 2022
Statut: epublish

Résumé

Several studies have ascertained that uPA and uPAR do participate in tumor progression and metastasis and are involved in cell adhesion, migration, invasion and survival, as well as angiogenesis. Increased levels of uPA and uPAR in tumor tissues, stroma and biological fluids correlate with adverse clinic-pathologic features and poor patient outcomes. After binding to uPAR, uPA activates plasminogen to plasmin, a broad-spectrum matrix- and fibrin-degrading enzyme able to facilitate tumor cell invasion and dissemination to distant sites. Moreover, uPAR activated by uPA regulates most cancer cell activities by interacting with a broad range of cell membrane receptors. These findings make uPA and uPAR not only promising diagnostic and prognostic markers but also attractive targets for developing anticancer therapies. In this review, we debate the uPA/uPAR structure-function relationship as well as give an update on the molecules that interfere with or inhibit uPA/uPAR functions. Additionally, the possible clinical development of these compounds is discussed.

Identifiants

pubmed: 35158766
pii: cancers14030498
doi: 10.3390/cancers14030498
pmc: PMC8833673
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Immunol. 2003 Aug 15;171(4):2050-6
pubmed: 12902510
Nat Rev Mol Cell Biol. 2002 Dec;3(12):932-43
pubmed: 12461559
Thromb Haemost. 2005 Feb;93(2):205-11
pubmed: 15711734
J Cell Sci. 2006 Aug 15;119(Pt 16):3424-34
pubmed: 16882693
Curr Pharm Des. 2011;17(19):1944-61
pubmed: 21711235
Drug Discov Today. 2002 Oct 15;7(20):1047-55
pubmed: 12546894
J Mol Biol. 2006 Oct 20;363(2):482-95
pubmed: 16979660
Sci Signal. 2015 Nov 17;8(403):ra117
pubmed: 26577922
Theranostics. 2015 Sep 13;5(12):1303-16
pubmed: 26516369
Cancer Cell Int. 2014 Mar 25;14:27
pubmed: 24666548
ACS Nano. 2010 Sep 28;4(9):4967-70
pubmed: 20873786
Theranostics. 2014 Mar 24;4(6):642-59
pubmed: 24723985
J Biol Chem. 1992 Feb 25;267(6):3878-85
pubmed: 1310986
J Thromb Haemost. 2010 Dec;8(12):2789-99
pubmed: 20880257
Int J Nanomedicine. 2015 Aug 24;10:5327-42
pubmed: 26346331
J Pharm Biomed Anal. 2018 Feb 20;150:39-42
pubmed: 29216583
Curr Top Microbiol Immunol. 1996;213 ( Pt 3):101-12
pubmed: 8815000
Cancers (Basel). 2020 Aug 24;12(9):
pubmed: 32847144
Front Cell Dev Biol. 2021 Aug 20;9:732015
pubmed: 34490277
Int J Mol Sci. 2021 Mar 15;22(6):
pubmed: 33804289
Oncotarget. 2017 Sep 23;9(15):11938-11947
pubmed: 29552283
J Biol Chem. 2006 May 12;281(19):13021-13029
pubmed: 16510444
Eur J Med Chem. 2018 Jan 1;143:348-360
pubmed: 29202399
J Biol Chem. 2007 May 4;282(18):13561-72
pubmed: 17355965
Nucl Med Biol. 2013 Jul;40(5):618-24
pubmed: 23602763
J Control Release. 2011 Feb 10;149(3):314-22
pubmed: 21047537
Clin Exp Metastasis. 1997 Jul;15(4):440-6
pubmed: 9219733
J Cell Biol. 2003 Oct 13;163(1):177-88
pubmed: 14557254
J Biol Chem. 2005 Jul 1;280(26):24792-803
pubmed: 15863511
Mol Cancer Ther. 2013 Aug;12(8):1402-16
pubmed: 23699658
Curr Pharm Des. 2003;9(19):1499-528
pubmed: 12871065
Nanotheranostics. 2017 Jul 11;1(4):346-357
pubmed: 29071198
Oncol Res. 2022 Jan 31;28(9):873-884
pubmed: 34315564
Cancer Res. 2002 Aug 15;62(16):4678-84
pubmed: 12183425
Structure. 1995 Jul 15;3(7):681-91
pubmed: 8591045
Thromb Haemost. 2005 Apr;93(4):779-86
pubmed: 15841327
Cells. 2020 Apr 24;9(4):
pubmed: 32344648
J Biol Chem. 2005 Jul 1;280(26):25225-32
pubmed: 15866865
Sci Rep. 2019 Feb 19;9(1):2318
pubmed: 30783124
J Pharmacol Exp Ther. 2010 Apr;333(1):129-39
pubmed: 20061445
FEBS Lett. 1994 Aug 1;349(2):163-8
pubmed: 8050560
Mol Pharm. 2021 Apr 5;18(4):1690-1698
pubmed: 33734721
Clin Cancer Res. 2001 Apr;7(4):1087-93
pubmed: 11309361
Br J Cancer. 2009 Sep 15;101(6):992-7
pubmed: 19672256
Gynecol Oncol. 2005 Oct;99(1):50-7
pubmed: 16023182
Mol Cancer Ther. 2009 Sep;8(9):2708-17
pubmed: 19706734
J Biol Chem. 2004 Jan 9;279(2):1400-7
pubmed: 14602715
EBioMedicine. 2019 Jan;39:194-206
pubmed: 30611716
Oncogene. 2001 Apr 12;20(16):2032-43
pubmed: 11360187
Curr Drug Targets. 2011 Nov;12(12):1744-60
pubmed: 21707477
Mol Pharmacol. 2015 Apr;87(4):683-96
pubmed: 25634671
J Nucl Med. 2021 Mar;62(3):354-359
pubmed: 32764119
Neurosurg Focus. 2006 Apr 15;20(4):E23
pubmed: 16709029
Oncogene. 2003 Sep 4;22(38):5967-75
pubmed: 12955075
Nat Rev Mol Cell Biol. 2010 Jan;11(1):23-36
pubmed: 20027185
J Biol Chem. 1991 Jan 25;266(3):1926-33
pubmed: 1846368
Neoplasia. 2010 Oct;12(10):778-88
pubmed: 20927316
Thromb Haemost. 2005 Feb;93(2):192-8
pubmed: 15711732
Cancer Res. 1999 Oct 15;59(20):5307-14
pubmed: 10537314
FASEB J. 2000 Jul;14(10):1400-10
pubmed: 10877833
J Biol Chem. 2003 Mar 28;278(13):11449-56
pubmed: 12529357
Cell Mol Life Sci. 2000 Jan 20;57(1):25-40
pubmed: 10949579
J Exp Clin Cancer Res. 2017 Dec 08;36(1):180
pubmed: 29216889
Acta Biomater. 2014 Oct;10(10):4257-68
pubmed: 24969665
Mol Cancer Res. 2010 Feb;8(2):145-58
pubmed: 20145038
J Biol Chem. 2011 Sep 23;286(38):33544-56
pubmed: 21799009
Cell Mol Life Sci. 2018 May;75(10):1889-1907
pubmed: 29184982
Int Immunopharmacol. 2012 Nov;14(3):283-8
pubmed: 22863814
Cancer Res. 1995 Jan 1;55(1):90-5
pubmed: 7805047
Curr Med Chem. 2008;15(25):2559-73
pubmed: 18855679
J Biol Chem. 1994 Dec 23;269(51):32380-8
pubmed: 7528215
Nat Biotechnol. 2006 Sep;24(9):1065-6
pubmed: 16964204
J Cell Biol. 2007 Jun 4;177(5):927-39
pubmed: 17548516
Sci Rep. 2017 May 2;7(1):1312
pubmed: 28465589
Biol Chem. 2001 Aug;382(8):1197-205
pubmed: 11592401
Clin Cancer Res. 2010 Jul 15;16(14):3607-17
pubmed: 20519360
Cancer Gene Ther. 2003 Feb;10(2):112-20
pubmed: 12536199
Nucl Med Biol. 2014 Mar;41(3):290-5
pubmed: 24533988
Science. 1996 Sep 13;273(5281):1551-5
pubmed: 8703217
J Biol Chem. 1987 Apr 5;262(10):4437-40
pubmed: 3031025
J Nucl Med. 2012 Jan;53(1):138-45
pubmed: 22213823
EMBO J. 1997 Dec 15;16(24):7279-86
pubmed: 9405357
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8484-9
pubmed: 10890917
J Biol Chem. 2004 Aug 6;279(32):33613-22
pubmed: 15150279
Thromb Haemost. 2013 Feb;109(2):309-18
pubmed: 23238745
Theranostics. 2019 Jan 25;9(3):884-899
pubmed: 30809315
ACS Chem Biol. 2011 Nov 18;6(11):1232-43
pubmed: 21875078
Mol Cancer Ther. 2013 Dec;12(12):2628-39
pubmed: 24061648
EMBO J. 2005 May 4;24(9):1655-63
pubmed: 15861141
PLoS One. 2012;7(9):e44806
pubmed: 23049759
Cancer Lett. 2010 Feb 28;288(2):251-60
pubmed: 19664879
Am J Pathol. 2001 Sep;159(3):971-82
pubmed: 11549590
J Neurosurg. 2011 Jun;114(6):1662-71
pubmed: 21294620
J Natl Cancer Inst. 2002 Apr 17;94(8):597-606
pubmed: 11959893
Bioorg Med Chem. 2012 Aug 1;20(15):4760-73
pubmed: 22771232
Clin Cancer Res. 2005 May 15;11(10):3879-88
pubmed: 15897589
Mol Biol Cell. 2001 Oct;12(10):2975-86
pubmed: 11598185
Biochemistry. 2001 Oct 9;40(40):12157-68
pubmed: 11580291
Int J Cancer. 2013 Oct 15;133(8):1936-44
pubmed: 23553371
Semin Thromb Hemost. 2013 Jun;39(4):382-91
pubmed: 23532574
PLoS One. 2015 May 04;10(5):e0126172
pubmed: 25938482
J Biol Chem. 2002 Dec 6;277(49):46932-9
pubmed: 12297505
Oncogene. 2002 Apr 11;21(16):2513-24
pubmed: 11971186
J Biol Chem. 1994 May 20;269(20):14746-50
pubmed: 7514182
Clin Biochem. 2004 Jul;37(7):541-8
pubmed: 15234235
PLoS One. 2014 Jan 21;9(1):e85349
pubmed: 24465541
J Cell Mol Med. 2015 Sep;19(9):2262-72
pubmed: 26082201
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820973280
pubmed: 33251986
Blood. 2005 Mar 1;105(5):2198-205
pubmed: 15494432
J Biol Chem. 1991 May 15;266(14):8655-8
pubmed: 1851152
Cancer Cell. 2002 Jun;1(5):445-57
pubmed: 12124174
Nat Rev Drug Discov. 2020 Jun;19(6):389-413
pubmed: 32494050
Thromb Haemost. 1999 Aug;82(2):259-70
pubmed: 10605712
J Biol Chem. 2006 May 26;281(21):14852-63
pubmed: 16547007
J Biol Chem. 2003 Aug 8;278(32):29863-72
pubmed: 12754207
Clin Cancer Res. 1997 Aug;3(8):1299-308
pubmed: 9815812
Adv Cancer Res. 1985;44:139-266
pubmed: 2930999
Theranostics. 2013 Aug 03;3(9):618-32
pubmed: 24052804
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3992-6
pubmed: 2023947
J Cell Biol. 1985 Jan;100(1):86-92
pubmed: 3880760
Eur J Biochem. 1997 Jan 15;243(1-2):21-6
pubmed: 9030717
Curr Pharm Des. 2011;17(19):1970-8
pubmed: 21711234
Eur J Biochem. 1996 May 1;237(3):743-51
pubmed: 8647121
Cancer Res. 2003 Apr 1;63(7):1684-95
pubmed: 12670923
Gene Ther. 2005 Apr;12(8):702-14
pubmed: 15674398
Curr Pharm Des. 2011;17(19):1874-89
pubmed: 21711237
J Cell Biol. 2001 Mar 19;152(6):1145-57
pubmed: 11257116
J Nucl Med. 2017 Mar;58(3):379-386
pubmed: 27609788
Clin Cancer Res. 2009 Jul 15;15(14):4722-32
pubmed: 19584158
Mol Cancer Ther. 2013 Oct;12(10):1981-93
pubmed: 23939376
Gynecol Oncol. 2008 Oct;111(1):89-94
pubmed: 18760451
FEBS Lett. 2008 Apr 2;582(7):1141-6
pubmed: 18339322
Theranostics. 2013 Jun 25;3(7):496-506
pubmed: 23843897
Int J Cancer. 1997 Jul 3;72(1):1-22
pubmed: 9212216
Arch Pharm Res. 2017 Jun;40(6):746-759
pubmed: 28560500
Exp Cell Res. 1999 Jul 10;250(1):231-40
pubmed: 10388537
J Exp Clin Cancer Res. 2018 Apr 3;37(1):74
pubmed: 29615071
Mol Cancer Ther. 2007 Apr;6(4):1348-56
pubmed: 17431113
FEBS Lett. 2002 Sep 25;528(1-3):212-6
pubmed: 12297307
BMC Cancer. 2019 Dec 2;19(1):1169
pubmed: 31791275
Oncogenesis. 2013 Jun 24;2:e53
pubmed: 23797476
Bone Res. 2020 Apr 17;8:18
pubmed: 32337090
J Cell Biol. 2005 Jan 31;168(3):501-11
pubmed: 15684035
Bioorg Med Chem Lett. 2011 Nov 15;21(22):6760-6
pubmed: 21978672
Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1104-17
pubmed: 11451738
Cell Mol Life Sci. 2011 Jul;68(14):2453-67
pubmed: 20972812
J Cell Sci. 2004 Jun 15;117(Pt 14):2909-16
pubmed: 15173320
Nucl Med Biol. 2012 Oct;39(7):962-9
pubmed: 22739362
Breast Care (Basel). 2008;3(s2):25-28
pubmed: 20824011
Cancer Sci. 2007 Feb;98(2):253-8
pubmed: 17233842
Int J Mol Sci. 2021 Dec 29;23(1):
pubmed: 35008762
Cell Mol Life Sci. 2021 Mar;78(6):3057-3072
pubmed: 33237352
Cell Mol Life Sci. 2007 May;64(9):1033-7
pubmed: 17372678
Science. 2006 Feb 3;311(5761):656-9
pubmed: 16456079
Biomolecules. 2020 Jun 25;10(6):
pubmed: 32630411
Clin Pharmacol. 2018 Sep 26;10:113-121
pubmed: 30288129
Cancer Biol Ther. 2011 Mar 1;11(5):524-34
pubmed: 21258214
J Neurooncol. 2011 Jun;103(2):255-66
pubmed: 20830604
J Cell Biol. 1999 Jul 12;146(1):149-64
pubmed: 10402467
Comb Chem High Throughput Screen. 2009 Dec;12(10):961-7
pubmed: 20025562
Clin Exp Metastasis. 2005;22(8):643-52
pubmed: 16649073
Melanoma Res. 2015 Feb;25(1):15-21
pubmed: 25405459
Front Pharmacol. 2015 Jul 27;6:154
pubmed: 26283964
ACS Med Chem Lett. 2020 Dec 10;12(1):60-66
pubmed: 33488965
Biopolymers. 1997 Apr 15;41(5):569-90
pubmed: 9095678
Br J Cancer. 2013 Mar 5;108(4):766-70
pubmed: 23412098
Thromb Haemost. 2007 Mar;97(3):336-42
pubmed: 17334498
Proc Natl Acad Sci U S A. 1985 Aug;82(15):4939-43
pubmed: 2991901
Curr Oncol. 2020 Feb;27(Suppl 1):17-23
pubmed: 32174754
Int J Mol Sci. 2021 Apr 16;22(8):
pubmed: 33923400
J Neurooncol. 2009 Dec;95(3):331-342
pubmed: 19517064
Curr Opin Cell Biol. 2000 Oct;12(5):613-20
pubmed: 10978898
J Biol Chem. 2005 Apr 29;280(17):17449-57
pubmed: 15728176
Lung Cancer. 2011 Dec;74(3):510-5
pubmed: 21640427
J Biol Chem. 1992 Sep 5;267(25):18224-9
pubmed: 1381366
PLoS One. 2009;4(2):e4617
pubmed: 19242538
Immunol Today. 1997 Sep;18(9):415-7
pubmed: 9293155
Chembiochem. 2013 May 10;14(7):882-9
pubmed: 23520074
J Exp Clin Cancer Res. 2019 Nov 8;38(1):459
pubmed: 31703596
Vet Comp Oncol. 2020 Dec;18(4):664-674
pubmed: 32187827
J Cell Biol. 1999 Oct 4;147(1):89-104
pubmed: 10508858
Cardiovasc Res. 2012 Apr 1;94(1):125-35
pubmed: 22287577
Clin Cancer Res. 2007 Jul 15;13(14):4051-60
pubmed: 17634529
Oral Oncol. 2012 Dec;48(12):1202-7
pubmed: 22818892
BMC Cancer. 2016 Jul 18;16:490
pubmed: 27432059
J Neurooncol. 2012 Sep;109(2):229-38
pubmed: 22696210
ChemMedChem. 2021 Jan 19;16(2):377-387
pubmed: 33107192
Front Oncol. 2018 Feb 12;8:24
pubmed: 29484286
Gynecol Oncol. 2012 Jun;125(3):635-9
pubmed: 22446624
Biochemistry. 2000 Jan 25;39(3):508-15
pubmed: 10642175
Science. 1972 Apr 28;176(4033):355
pubmed: 17777707
Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22
pubmed: 12784997
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1359-64
pubmed: 11818541
J Biol Chem. 2000 Apr 7;275(14):10228-34
pubmed: 10744708
Mol Cancer Ther. 2017 May;16(5):956-965
pubmed: 28193671
J Biol Chem. 1989 Feb 5;264(4):2185-8
pubmed: 2521625

Auteurs

Maria Teresa Masucci (MT)

Neoplastic Progression Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Michele Minopoli (M)

Neoplastic Progression Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Gioconda Di Carluccio (G)

Neoplastic Progression Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Maria Letizia Motti (ML)

Department of Motor and Wellness Sciences, University "Parthenope", 80133 Naples, Italy.

Maria Vincenza Carriero (MV)

Neoplastic Progression Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.

Classifications MeSH